Immunic Archives - Catalyst Daily

Vidofludimus Calcium Shows Strong Efficacy in RRMS, Immunic, Inc. ($IMUX) Reports

Staff Writer - June 24, 2025 6:38 am

Immunic, Inc. (IMUX) announced new long-term open-label extension data from its phase 2 EMPhASIS trial. The trial involved their lead asset, vidofludimus calcium, an...

Smart Share Global ($EM) Rockets 28.5% After-Hours on Acquisition Proposal

August 15, 2025 5:06 pm

Earnings Per Share Losses Narrow for Jet AI ($JTAI) in Q2.

August 15, 2025 9:30 am

Workhorse Group ($WKHS) Shakes Up Expectations with Q2 Earnings

August 15, 2025 8:27 am

Tag: Immunic

Vidofludimus Calcium Shows Strong Efficacy in RRMS, Immunic, Inc. ($IMUX) Reports

Smart Share Global ($EM) Rockets 28.5% After-Hours on Acquisition Proposal

Earnings Per Share Losses Narrow for Jet AI ($JTAI) in Q2.

Workhorse Group ($WKHS) Shakes Up Expectations with Q2 Earnings